Coya Therapeutics, Inc. (COYA) Ownership

NASDAQ: COYATop holders, insider trades and short interest.

COYA ownership summary

as of October 17, 2026
Institutions
33.3%
of shares outstanding
Insiders
14.69%
of shares outstanding
Shares outstanding
23.5M
Float
17.5M
shares available to trade
Short interest
5.13%
1.2M shares short
Days to cover
8.48
short interest up 0.3% vs prior month
  • Institutions 33.25%
  • Insiders 14.69%
  • Other investors 52.06%

COYA top institutional holders

20 largest
Coya Therapeutics, Inc. top institutional holders
#Holder% of sharesSharesValueChangeReported
1Vanguard Capital Management, LLC3.59%842K$3.6M−2,693 (−0.3%)June 30, 2026
2Alyeska Investment Group, L.P.3.41%800K$3.4M—June 30, 2026
3AIGH Capital Management, LLC2.69%632K$2.7M−343,492 (−35.2%)June 30, 2026
4CM Management, LLC1.71%400K$1.7M+25,000 (+6.7%)June 30, 2026
5Private Management Group Inc1.64%384K$1.6M+15,121 (+4.1%)June 30, 2026
6Marshall Wace Asset Management Ltd1.06%250K$1.1M+24,001 (+10.6%)June 30, 2026
7Geode Capital Management, LLC0.97%228K$970,033−5,159 (−2.2%)June 30, 2026
8Renaissance Technologies Corp0.82%193K$820,190+89,022 (+85.6%)June 30, 2026
9Prosight Management, LP0.72%170K$722,500−250,360 (−59.6%)June 30, 2026
10Dimensional Fund Advisors, Inc.0.66%156K$662,647+59,998 (+62.6%)June 30, 2026
11Vanguard Fiduciary Trust Co0.55%130K$550,592−10,335 (−7.4%)June 30, 2026
12JONES FINANCIAL COMPANIES LLLP0.47%111K$471,368+65,950 (+146.7%)June 30, 2026
13BlackRock Inc0.44%102K$435,234+19,639 (+23.7%)June 30, 2026
14Springbok Capital Management, LLC0.43%101K$430,652—June 30, 2026
15JBF Capital, Inc.0.43%100K$425,026—June 30, 2026
16Royal Bank of Canada0.40%93K$397,010+80,022 (+597.5%)June 30, 2026
17Morgan Stanley - Brokerage Accounts0.35%82K$348,950−3,594 (−4.2%)June 30, 2026
18State Street Corp0.34%80K$339,205—June 30, 2026
19683 Capital Management LLC0.30%70K$297,500−10,128 (−12.6%)March 31, 2026
20Susquehanna International Group, LLP0.26%61K$259,276+21,690 (+55.2%)June 30, 2026

Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 9 holders added 400K shares and 7 cut 626K.

COYA top mutual fund and ETF holders

20 largest
Coya Therapeutics, Inc. top fund holders
#Holder% of sharesSharesValueChangeReported
1Vanguard MStar Total Stk Mkt Idx Invest2.56%601K$2.6M—August 31, 2026
2Fidelity Extended Market Index0.47%109K$464,461+3,885 (+3.7%)August 31, 2026
3Dimensional US Small Cap ETF0.32%76K$321,122—September 30, 2026
4iShares Micro-Cap ETF0.27%63K$267,202−434 (−0.7%)September 30, 2026
5DFA US Micro Cap I0.16%39K$163,723+1,365 (+3.7%)August 31, 2026
6Fidelity Series Total Market Index0.14%32K$137,543—August 31, 2026
7Fidelity Total Market Index0.13%31K$132,311—August 31, 2026
8DFA US Small Cap I0.06%13K$55,705—August 31, 2026
9Avantis US Small Cap Equity ETF0.05%11K$47,676—September 30, 2026
10Vanguard Balanced Index Inv0.05%11K$46,334—August 31, 2026
11Vanguard MStar Inst Ttl StkMktIdxInstlPl0.04%10K$43,546—August 31, 2026
12Schwab Total Stock Market Index0.04%10K$42,500—August 31, 2026
13Fidelity Nasdaq Composite Index0.03%6,896$29,308−7,996 (−53.7%)August 31, 2026
14Vanguard U.S. Eq Idx £ Acc0.03%5,879$24,986—August 31, 2026
15Dimensional US Vector Equity ETF0.02%4,793$20,370—September 24, 2026
161290 VT Micro Cap K0.02%4,435$18,849—August 31, 2026
17Dimensional International Core Eq Acc0.02%4,192$17,816—August 31, 2026
18Dimensional World Equity GBP Acc0.02%3,807$16,180—August 31, 2026
19DFA US Vector Equity Class F0.02%3,576$15,198+3,576 (0.0%)July 31, 2026
20DFA US Vector Equity I0.01%3,506$14,900—August 31, 2026

Funds report holdings monthly or quarterly; dates differ by fund.

COYA insider transactions

latest 3
Coya Therapeutics, Inc. insider transactions
DateNameTransactionPriceSharesValue
2024-11-14David S SnyderBuy$7.191,800$12,942
2024-11-11Arun SwaminathanBuy$7.345,000$36,700
2024-11-11Fred GrossmanBuy$7.372,710$19,973

Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.

COYA shares outstanding

Shares outstanding

Year-end shares outstanding, adjusted for splits.

Who owns COYA

Institutional investors own 33.3% of Coya Therapeutics's shares and insiders 14.69%. The largest holder is Vanguard Capital Management, LLC with 3.59% of the shares (842K), as of June 30, 2026. Among the top 20 institutions, 9 added shares and 7 reduced their stake in the latest filings. Short interest is 5.13% of the float, or 8.48 days of average trading volume. The share count rose 153.4% since 2021.

Related: COYA analyst forecast, COYA key metrics. See the COYA stock overview for the latest quote and news.

COYA ownership FAQ

Who owns the most Coya Therapeutics stock?

The largest shareholders of Coya Therapeutics are Vanguard Capital Management, LLC (3.59%), Alyeska Investment Group, L.P. (3.41%), AIGH Capital Management, LLC (2.69%), CM Management, LLC (1.71%), Private Management Group Inc (1.64%).

What percentage of Coya Therapeutics is owned by institutions?

Institutions hold 33.3% of Coya Therapeutics's shares outstanding; insiders hold 14.69%.

Which funds own Coya Therapeutics?

The largest fund holders of Coya Therapeutics are Vanguard MStar Total Stk Mkt Idx Invest (2.56%), Fidelity Extended Market Index (0.47%), Dimensional US Small Cap ETF (0.32%), iShares Micro-Cap ETF (0.27%), DFA US Micro Cap I (0.16%).

What is Coya Therapeutics's short interest?

1.2M shares of Coya Therapeutics were sold short, 5.13% of the float; at the average daily volume it would take 8.48 days to cover.

Are insiders buying or selling Coya Therapeutics?

Of the latest 3 reported insider transactions in Coya Therapeutics (since November 11, 2024), 3 were purchases and 0 were sales.

How many shares of Coya Therapeutics are outstanding?

Coya Therapeutics has 23.5M shares outstanding, of which 17.5M are in the public float.

Biotechnology: ownership